| Willmitzer, Lothar (Max Planck 201006 Managing Director MPI for Molecular Plant Physiology) |
President/Director/Head of Research Organisation/Unit |
Max Planck Society for the Advancement of Science |
Germany |
| Willms, Andrea (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
| Wills, Robert J. (Rob) (at JnJ 25 years before Roche) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
| Wilmanns, Max (GSK Stockmann 201704 Lawyer + Partner at Hamburg Office) |
Attorney / Lawyer |
|
|
| Wilson, Charles (Chuck) (Novartis 201204 Global Head Strategic Alliances before Archemix + Univ California Santa Cruz) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Wilson, Dow R. (Varian Medical Systems 201412 CEO) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
United States (USA) |
| Wilton, Jane (Philogen SpA 201510 Director Business Development) |
Business Development Manager / Strategy Manager |
Philogen (Group) |
Italy |
| Wimmer, Bartl (Synlab 201408 Managing Director) |
Managing Director |
Synlab (Group) |
Germany |
| Wimmer, Bernhard (BioM AG 200603) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Wimmer, Sylvia (Wilex 201403 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Heidelberg Pharma (Group) |
Germany |
| Windeler, Jürgen (IQWiG 201312 Head of Institute) |
President/Director/Head Business Group/Unit/Division |
IQWiG (German Centre for Quality and Efficiency in Health Services) |
Germany |
| Windels, Hilde (Biocartis 201107– CFO + managing director Biocartis NV before Devgen 1999–2008 CFO) |
Chief Financial Officer (CFO) |
Biocartis (Group) |
Switzerland |
| Windhab, Norbert |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
| Windham-Bannister, Susan (Massachusetts Life Sciences Center 201310 CEO) |
Chief Executive Officer (CEO) |
Massachusetts (govt region) |
United States (USA) |
| Windisch, Jörg (Affimed 201601– COO before 20y at Sandoz Biopharmaceuticals (Novartis)) |
Chief Operating Officer (COO) |
Affimed (Group) |
Germany |
| Windisch, Manfred (JSW-Research 200512 CEO) |
Chief Executive Officer (CEO) |
JSW-Research (Group) |
Austria |
| Wingender, Edgar (geneXplain 201004– Managing Director + Univ Medical Center Göttingen 201601 Institute of Bioinform) |
Managing Director |
geneXplain GmbH |
Germany |
| Winkler, Karl (Anagnostics 201210– Sales Manager direct sales to hospitals in DE + AT + CH before Heinen & Löwenstein) |
Sales Manager / Marketing Manager |
Cube Dx GmbH |
Austria |
| Winkler, Katrin (Qiagen 200810 Associate Director Global Organisational Professional Development) |
training (employee) |
Qiagen (Group) |
Germany |
| Winkler, Ron (High-Tech Gründerfonds 201207 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Winnacker, Ernst-Ludwig |
n. a. |
DFG (Deutsche Forschungsgemeinschaft) |
Germany |
| Winnen, Pascal (Hemex AG 201901 CEO) |
Chief Executive Officer (CEO) |
Hemex AG |
|
| Winroth, Jörgen (Swedish Orphan Biovitrum 201512 VP + Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Winter, Babette |
n. a. |
Tecmedic GmbH |
Germany |
| Winter, Martin (Cetics 201103c BusDev + Co-founder + Lab Automation Network before Accelab GmbH) |
Business Development Manager / Strategy Manager |
Cetics Healthcare Technologies, Dr. Martin Winter |
Germany |
| Winter, Nina (miRdetect GmbH 2016– Managing Director + Company Founder) |
Managing Director |
miRdetect GmbH |
Germany |
| Winter, Peter (GenXPro GmbH 201402 Managing Director) |
Managing Director |
GenXPro GmbH |
Germany |
| Winter, Thomas (Mediatum 2011 Managing Director Mediatum Deutschland GmbH joined 2009) |
Managing Director |
Mediatum (Group) |
Germany |
| Winterhalter, Christoph (Rentschler –201411–201802 Business Development Manager LEFT 2/18) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Winterhalter, Mathias (Jacobs Univ Bremen 2009 Professor School of Engineering and Science) |
Professor |
Jacobs University Bremen gGmbH (JUB) |
Germany |
| Winzer, Ludwig (Ocimum Germany GmbH 200606– Managing Director) |
Managing Director |
Ficus Enterprises (Group) |
Germany |
| Winzer, Marco (High-Tech Gründerfonds 200701 Investment Manager) |
n. a. |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Wiring, Roland (CMS 201508 Attorney at CMS Hasche Sigle Hamburg advising life sciences + med tech firms) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Wirsching, Sandra (Biocom AG 2005– Editor) |
Editor / Publisher |
Biocom (Group) |
Germany |
| Wirth, Jean-Charles (Merck (DE) 201708 Head of Applied Solutions business unit, Life Science) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Wirth, Thomas (LSCN Ltd 201710 Managing Director) |
Managing Director |
LSCN Ltd. (Life Science Consulting Network) (DE) |
Germany |
| Wirtz, Ralph Markus (Stratifyer Molecular Pathology GmbH 201311 Managing Director) |
Managing Director |
Stratifyer Molecular Pathology GmbH |
Germany |
| Wirz, Konrad P. (Speedel 200508 CFO) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
| Wisniewska, Joanna (ChemTaurus GmbH 201202 Managing Director) |
Managing Director |
ChemTaurus GmbH |
Germany |
| Wissmann, Dirk (Ametek 201105 Product Manager XRF at SPECTRO Analytical Instruments) |
Product Manager (personnel) |
AMETEK (Group) |
Germany |
| Wiszniewski, Ludovic (Epithelix 201207 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Epithelix Sàrl |
Switzerland |
| Witt, Sabine (Baltic Analytics GmbH 201112 Managing Director) |
Managing Director |
Baltic Analytics GmbH |
Germany |
| Witte, Rolf (Fundamenta Capital AG 200001–201301 + LimFlow GmbH 201207–2013 before Warburg Glycomed) |
Managing Director |
Fundamenta Life-Science GmbH |
Germany |
| Witte, Stephan (Akesion GmbH 201504 Managing Director) |
Managing Director |
Akesion GmbH |
Germany |
| Wittenberger, Timo (Altana Pharma 200501) |
n. a. |
Takeda (Group) |
Germany |
| Wittig, Burghardt (Mologen 200708 CEO) |
Chief Executive Officer (CEO) |
Mologen (Group) |
Germany |
| Wittke, Johann-Wolfgang (Medizinisches Labor Bremen 2ß01709 Managing Director) |
Managing Director |
Sonic Healthcare (Group) |
Germany |
| Wittmeier, Sebastian (Curefab GmbH 2008– CTO + Co-founder) |
Chief Technology/Technical Officer (CTO) |
Curefab GmbH |
Germany |
| Witty, Andrew (Hatteras Venture Partners 201709– Venture Partner former GSK CEO 2008–2017 joined 1985) |
Partner (venture partner) |
Hatteras Venture Partners (HVP) |
United States (USA) |
| Wixforth, Achim (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
| Wnendt, Stephan (MLM Medical Labs 200801– CEO before Paion Deutschland + ViaCell + Kourion Therapeutics) |
Managing Director |
MLM Medical Labs GmbH |
Germany |
| Wocheslander, Franz (Bayern Kapital 201112 Investment Manager) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Wodarz, Katharina (McDermott Will & Emery 201702 Partner in Munich) |
Attorney / Lawyer |
McDermott Will & Emery (MWE) (Group) |
Germany |
| Woehlbier, Jens (Körber 201904– CEO of Werum IT Solutions before over 20 years at Accenture) |
Chief Executive Officer (CEO) |
Körber (Group) |
Germany |
| Woerle, Hans-Juergen (Boehringer 201706 Global VP Medicine) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Woestenhemke, Katja (AiCuris 201608) |
Public Relations Manager / Investor Relations Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Wohlers, Katja |
n. a. |
|
|
| Wohlfahrt, Klaus |
n. a. |
Quantifoil Instruments GmbH |
Germany |
| Wohlhauser, Patrik (Evonik 201201 Executive Board Director) |
Board member, executive |
Evonik (Group) |
Germany |
| Wohltmann, Meike (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
| Woiwode, Tom (Versant Ventures 201404 before Synosis + Xenoport) |
Venture Partner |
Versant Ventures |
United States (USA) |
| Wojcik, Jérôme (Quartz Bio 201209– CEO + founder) |
Chief Executive Officer (CEO) |
Quartz Bio S.A. |
Switzerland |
| Wojczewski, Sylvia (BioSpring GmbH 201205 Managing Director) |
Managing Director |
BioSpring GmbH |
Germany |
| Woker, Mathias (AMSilk 201210– CBO located in Boston before Graffinity 200603 Senior VP BusDev US) |
Business Development Manager / Strategy Manager |
AMSilk GmbH |
Germany |
| Woler, Charles (Biomnis 201210– CEO before Endotis Pharma CEO) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
France |
| Wolf, Andreas (Micro-Biolytics GmbH 201109 Managing Director) |
Managing Director |
micro-biolytics GmbH |
Germany |
| Wolf, Holger (CyBio 200803– CEO before Coloplast VP Sales Central Europe before Kneipp Group CEO) |
Chief Executive Officer (CEO) |
Endress+Hauser (Group) |
Germany |
| Wolf, Jan-Christoph (Plasmion GmbH 201806 Managing Director) |
Managing Director |
Plasmion GmbH |
Germany |
| Wolf, Markus (European ScreeningPort 200810) |
n. a. |
Fraunhofer (Group) |
Germany |
| Wolf, Michael (Affimed + Sygnis 201603 Finance) |
n. a. |
Affimed (Group) |
Germany |
| Wolf, Rainer (BASF 201201 Senior Scientist GMC Polymer Physics and Analytics) |
Research & Development Manager |
BASF (Group) |
Germany |
| Wolf, Stefan (Thermo Fisher 201601– Division President IDD before Siemens + Dade Behring) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Wolf, Wieland W. (Minapharm 201006– CEO ProBioGen before Rentschler Biotechnologie GmbH) |
Chief Executive Officer (CEO) |
Minapharm (Group) |
Germany |
| Wolff, Marc (Aldevron 201805– CFO before Sancilio Pharmaceuticals + JHP Pharmaceuticals + ReSearch + Catalent) |
Chief Financial Officer (CFO) |
Aldevron (Group) |
United States (USA) |
| Wolff, Uwe (NAIMA Strategic Legal Services 201508 + DBI AG 201508 Supervisor Board Member) |
consulting (economic) |
NAIMA Strategic Legal Services GmbH |
Germany |
| Wolfinger, Marcus (Stratec Biomedical 201104 CEO before CFO) |
Chief Executive Officer (CEO) |
Stratec (Group) |
Germany |
| Wollenhaupt, Jochen (Methrom 201301– Head of Distribution of Deutsche Methrom GmbH & Co KG) |
Sales Manager / Marketing Manager |
Metrohm (Group) |
Germany |
| Wollman, Lilly (Generation Investment Management 201901 Co-Head Growth Equity Team) |
Investment Manager |
Generation Investment Management LLP |
United Kingdom (GB) |
| Wonerow, Peter (Science4Life 201710 Office Head) |
Cluster Manager |
Science4Life e. V. |
Germany |
| Wood, Clive R. (Boehringer 201403– SVP Discovery Researchbefore Bayer HealthCare + Dyax) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Woodford, Neil (Woodford Investment) |
Investment Manager |
Woodford Investment (Group) |
United Kingdom (GB) |
| Woodrow, Gordon (Proteros Biostructures 201008 EVP Strategic Alliances) |
Business Development Manager / Strategy Manager |
Proteros (Group) |
United Kingdom (GB) |
| Woods, Kate (Northbank 200411) |
n. a. |
Instinctif Partners (Group) |
Germany |
| Woods, R. Keith (Argen-X 201804– COO before Alexion + Roche + Amgen + Eisai) |
Chief Operating Officer (COO) |
Argenx (Argen-X) (Group) |
Netherlands |
| Woolfenden, Elizabeth (Liz) (Markes 200902 Director) |
President/Director/Head Business Group/Unit/Division |
Schauenburg (Group) |
United Kingdom (GB) |
| Woolford, John (Westwicke Partners 201807) |
Public Relations Manager / Investor Relations Manager |
Westwicke Partners LLC |
United States (USA) |
| Worland, Steve (Effector Therapeutics 201512 CEO before Anadys + Pfizer) |
Chief Executive Officer (CEO) |
Effector Therapeutics Inc. |
United States (USA) |
| Worseck, Josephine (Metabolomic Discoveries 201501 Head of Business Development) |
Business Development Manager / Strategy Manager |
Metabolon (Group) |
Germany |
| Wortelmann, Thomas (GAS GmbH 201311 Managing Director) |
Managing Director |
Imspex (Group) |
Germany |
| Wozniewski, Thomas (Takeda 201611 Global Manufacturing + Supply Officer) |
Production Manager |
Takeda (Group) |
Japan |
| Wright, Edward (Bayer 201611 Bayer Yakuhin) |
n. a. |
Bayer (Group) |
Japan |
| Wright, Teresa (Roche Molecular 200809 CMO) |
Chief Medical Officer (CMO) |
Roche (Group) |
United States (USA) |
| Wright, Timothy (Novartis 201111– Global Head Development at Novartis Pharmaceuticals joined Novartis 2004) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
|
| Wrobel, Walter-G. (Retina Implant 201603 CEO) |
Chief Executive Officer (CEO) |
Retina Implant AG |
Germany |
| Wu, Ching (Excellims 201406 CEO) |
Chief Executive Officer (CEO) |
Excellims Corporation |
United States (USA) |
| Wu, Xiaodong (China Medical Technologies 201108 CEO) |
Chief Executive Officer (CEO) |
China Medical Technologies (Group) |
China |
| Wu, Xu (Creat 201704 CEO) |
Chief Executive Officer (CEO) |
Creat (Group) |
China |
| Wulf, Sylke (Thermo Fisher 201006 Thermo Fisher Deutschland Regional Head Chromatography North) |
Regional manager |
Thermo Fisher (Group) |
Germany |
| Wulf-Fuhrmann, Gabriele (Niedersachsen (govt) 201410– Vice President of LAVES) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Wulfetange, Camilla (Scienion 201206) |
n. a. |
Scienion (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 65 66 67 
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
